Rogers Campbell 4

4 · Heartflow, Inc. · Filed Mar 23, 2026

AI-generated summary of this filing

Updated Mar 23, 2026

Heartflow (HTFL) CMO Rogers Campbell Exercises Options, Sells Shares

What Happened

Rogers Campbell, Chief Medical Officer of Heartflow (HTFL), exercised stock options on March 19, 2026 to acquire 67,017 shares at an exercise price of $2.22 per share (total cost ≈ $148,777). He sold 64,533 shares in an open‑market transaction that day for a weighted average price of $25.69, generating proceeds of $1,658,033. The sale included 16,918 shares he already held and the option exercise and sale of 47,615 shares.

Key Details

Transaction date: March 19, 2026; Form filed: March 23, 2026 (timely — filed within two business days).
Exercise price: $2.22 per share; total exercise cost ≈ $148,777.
Sale: 64,533 shares at weighted avg $25.69 (trade prices ranged $25.00–$28.00); proceeds $1,658,033.
Footnotes: transactions were effected under a Rule 10b5‑1 trading plan adopted Sept 12, 2025 (F1–F3). The filing notes multiple trades and provides a weighted average sale price (F4). Option vests in monthly installments through July 1, 2027 (F5).
Derivative reporting: the filing also shows derivative disposals reported at $0.00 in connection with the option activity (per the Form).
Shares owned after the transaction: not disclosed in the provided excerpt of the filing.

Context

This was an option exercise followed by a prompt sale of shares (common practice to realize value or cover exercise/tax obligations). The transactions were executed pursuant to a pre‑arranged 10b5‑1 plan, meaning the trades were pre‑planned rather than ad hoc. This is primarily a liquidity event (sale) rather than a fresh insider purchase.

Form 4

Period: 2026-03-19

Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-03-19$2.22/sh+19,402$43,072→ 95,436 total
Exercise/Conversion
Common Stock
[F2]
2026-03-19$2.22/sh+47,615$105,705→ 143,051 total
Sale
Common Stock
[F3][F4]
2026-03-19$25.69/sh−64,533$1,658,033→ 78,518 total
Exercise/Conversion
Stock Option
[F1][F5]
2026-03-19−19,402→ 189,125 total
Exercise: $2.22Exp: 2033-07-10→ Common Stock (19,402 underlying)
Exercise/Conversion
Stock Option
[F2][F5]
2026-03-19−47,615→ 141,510 total
Exercise: $2.22Exp: 2033-07-10→ Common Stock (47,615 underlying)

Holdings

Footnotes (5)

[F1]The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
[F2]The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
[F3]Includes the sale of 16,918 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
[F4]This transaction was executed in multiple trades at price ranging from $25.00 to $28.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.

Signature

/s/ Nga Van, by power of attorney|2026-03-23

1 file